HPHA.DE XETRA
Heidelberg Pharma AG
1W: -8.9%
1M: -5.2%
3M: -9.6%
YTD: -18.7%
1Y: -48.4%
3Y: -32.1%
5Y: -65.6%
€2.35 ($2.62)
-0.01 (-0.42%)
Weekly Expected Move ±5.3%
€2
€2
€2
€2
€3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$38M
-37.2% ▼
5Y CAGR: +14.2%
Total Liabilities
$49M
+64.3% ▲
5Y CAGR: +48.8%
Shareholders Equity
-$11M
-135.4% ▼
Cash & Investments
$15M
-49.1% ▼
5Y CAGR: +24.6%
Total Debt
$1M
-94.7% ▼
5Y CAGR: +41.9%
Net Debt
-$14M
-85.4% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $6M | $81M | $43M | $29M | $15M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $6M | $81M | $43M | $29M | $15M |
| Net Receivables | $1M | $1M | $1M | $6M | $2M |
| Inventory | $746K | $5M | $10M | $12M | $11M |
| Other Current Assets | $676K | $513K | $847K | $0 | $0 |
| Total Current Assets | $9M | $88M | $57M | $48M | $28M |
| Property, Plant & Equip. | $4M | $4M | $4M | $3M | $912K |
| Goodwill & Intangibles | $9M | $9M | $9M | $9M | $9M |
| Long-Term Investments | $35K | $35K | $0 | $809K | $66K |
| Other Non-Current Assets | $13K | $6K | $975K | $0 | $0 |
| Total Non-Current Assets | $13M | $13M | $14M | $13M | $10M |
| Total Assets | $22M | $101M | $70M | $61M | $38M |
| — Liabilities — | |||||
| Accounts Payable | $903K | $3M | $8M | $6M | $7M |
| Short-Term Debt | $10M | $16M | $6M | $115K | $102K |
| Deferred Revenue | $491K | $5M | $621K | $1M | $27K |
| Other Current Liabilities | $3M | $4M | $6M | $660K | $4M |
| Total Current Liabilities | $15M | $28M | $20M | $8M | $11M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $1M |
| Other Non-Current Liab. | $0 | $0 | $0 | $22M | $0 |
| Total Non-Current Liabilities | $98K | $6M | $1M | $22M | $38M |
| Total Liabilities | $15M | $34M | $21M | $30M | $49M |
| — Equity — | |||||
| Common Stock | $34M | $47M | $47M | $47M | $47M |
| Retained Earnings | -$272M | -$291M | -$312M | -$331M | -$373M |
| Accumulated OCI | $6M | $7M | $0 | $2M | $2M |
| Total Stockholders Equity | $7M | $67M | $49M | $31M | -$11M |
| Total Liabilities & Equity | $22M | $101M | $70M | $61M | $38M |
| — Key Metrics — | |||||
| Total Debt | $11M | $16M | $6M | $22M | $1M |
| Net Debt | $4M | -$65M | -$38M | -$7M | -$14M |
| Total Investments | $35K | $35K | $0 | $809K | $66K |